At Confmeets Journals, the Editorial Board serves as the cornerstone of academic integrity and excellence. Comprising distinguished scholars and professionals across various disciplines, the board ensures that each manuscript undergoes a rigorous peer-review process aligned with the journal's mission.
Our board members are committed to upholding the integrity, quality, and ethical standards of scholarly publishing. They collaborate closely with authors, reviewers, and the Confmeets editorial team to uphold ethical practices, promotes transparency, and guarantee that every published article contributes meaningfully to the advancement of knowledge in its field.
Department: Division of Gynecologic Oncology
Affiliation: Division of Gynecologic Oncology, National Cancer Institute G Pascale IRCCS Pascale Foundation, Naples
Designation: Head Physician
Email: carlo.ronsini@istitutotumori.na.itCountry: Italy
Dr. Carlo Ronsini is an Italian gynecologic oncologist and surgeon currently serving as Head Physician of Gynecologic Oncology at the National Cancer Institute IRCCS Pascale Foundation in Naples, Italy. He completed his medical degree with highest honors at Università Cattolica del Sacro Cuore, Rome, and specialized in Gynecology and Obstetrics at G. d’Annunzio University, Chieti-Pescara. He holds advanced qualifications in minimally invasive gynecologic surgery and statistical methods for clinical research, and has been awarded National Scientific Qualification as Associate Professor in Gynecology and Obstetrics. His research focuses on endometrial and ovarian cancers, fertility preservation, and innovative surgical and therapeutic techniques such as HIPEC and robotic surgery. Dr. Ronsini has authored over 90 scientific publications, participated in major European conferences, and contributes actively to research networks in gynecologic oncology. His work emphasizes improving oncological outcomes and surgical precision in women’s reproductive health.
Affiliation: Oncology, Lanzhou University, Lanzhou
Department: Department of Oncology
Designation: Faculty
Email: zhouyq21@lzu.edu.cnCountry: China
Dr. Yongqiang Zhou is a cancer biologist and biomedical researcher affiliated with Lanzhou University, China. His work focuses on molecular and cellular mechanisms driving liver diseases, particularly hepatocellular carcinoma, fibrosis, and immune microenvironment modulation. He has authored multiple high-impact publications in journals such as Molecular Cancer, Cell Death and Disease, and The American Journal of Pathology. His research integrates molecular genetics, immunology, and systems biology to explore new therapeutic targets in liver regeneration and cancer progression.